Argentum Nitricum in cases of irritate bowel syndrome

Prospective interventional study to assess effectiveness of Argentum Nitricum in cases of Irritate Bowel Syndrome - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057286

Enrollment

Registered

2023-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K58- Irritable bowel syndrome

Interventions

Intervention1: ARGENTUM NITRICUM: Intervention is planned as administering Argentum Nitricum as decided to case or condition. each dose shall consist of 4-5 globules (no.30)of cane sugar, medicated wi

Eligibility

Inclusion criteria

Inclusion criteria: Pre diagnosed or with clinical presentation of IBS will be randomly selected confirmed with Rome criteria -All socio economic status

Exclusion criteria

Exclusion criteria: -Having gross pathological changes -Suffering from other diseases along with ibs -Cases with irregular follow ups -Pregnant and lactating woman -Severely ill patients who requires immidiate hospitalization

Design outcomes

Primary

Measure	Time frame
Effectiveness of Argentum Nitricum in cases of IBSTimepoint: 3 months,6 Months	—

Secondary

Measure	Time frame
To assess the impact of Irritable Bowel Syndrome on individuals using IBS severity scoring systemTimepoint: 3 months,6 Months	—

Countries

India

Contacts

Public ContactDr. Mahima Pandya

Jawaharlal Nehru Homoeopathic Medical College and Hospital,Parul University

munjal.thakarahmc@paruluniversity.ac.in9227926514

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026